ARCHIVES

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

This article is from The Cancer Letter archive.

Vol. 28 No. 02 | January 11, 2002

Download PDF Visit The Full Archive

Related Articles

Yarbro-Chabner Debate Continues

April 29, 1983

Clinical Trials Approved By NCI During November Are Listed

December 27, 2002

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate

February 26, 1999

New Analyses of PCPT Give Stronger Justification Use of Finasteride To Prevent Prostate Cancer.

May 23, 2008